| pubmed-article:2342668 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0001899 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0201899 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0376147 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0560219 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0524587 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C2257651 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0201836 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:2342668 | lifeskim:mentions | umls-concept:C0442818 | lld:lifeskim |
| pubmed-article:2342668 | pubmed:issue | 887 | lld:pubmed |
| pubmed-article:2342668 | pubmed:dateCreated | 1990-6-26 | lld:pubmed |
| pubmed-article:2342668 | pubmed:abstractText | The usefulness of the serum aspartate aminotransferase (AST): serum alanine aminotransferase (ALT) ratio as a guide to the presence of alcoholism was evaluated in four groups of patients. In alcoholics with elevated transaminases the mean AST:ALT ratio was found to be 1.50 (95% confidence interval (CI): 1.49-1.51), in hepatitis B infection 0.51 (95% CI: 0.50-0.52), in liver cancer 1.25 (95% CI: 1.20-1.29), and in nonmalignant obstructive jaundice 0.59 (95% CI: 0.57-0.61). In alcoholics with normal transaminases the AST:ALT ratio was 1.64 (95% CI: 1.61-1.67). The combination of an AST:ALT ratio of greater than 1.00 with an erythrocyte mean cell volume (MCV) above 90.0 fL resulted in a sensitivity of 97.3% and a specificity of 88.9% for detecting alcoholism in these four groups of patients. | lld:pubmed |
| pubmed-article:2342668 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2342668 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2342668 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2342668 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2342668 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2342668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2342668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2342668 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2342668 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2342668 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:2342668 | pubmed:issn | 0028-8446 | lld:pubmed |
| pubmed-article:2342668 | pubmed:author | pubmed-author:RobinsonG MGM | lld:pubmed |
| pubmed-article:2342668 | pubmed:author | pubmed-author:SparkA HAH | lld:pubmed |
| pubmed-article:2342668 | pubmed:author | pubmed-author:KawachiII | lld:pubmed |
| pubmed-article:2342668 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2342668 | pubmed:day | 11 | lld:pubmed |
| pubmed-article:2342668 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:2342668 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2342668 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2342668 | pubmed:pagination | 145-8 | lld:pubmed |
| pubmed-article:2342668 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:meshHeading | pubmed-meshheading:2342668-... | lld:pubmed |
| pubmed-article:2342668 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2342668 | pubmed:articleTitle | A combination of raised serum AST:ALT ratio and erythrocyte mean cell volume level detects excessive alcohol consumption. | lld:pubmed |
| pubmed-article:2342668 | pubmed:affiliation | Department of Community Health, Wellington School of Medicine. | lld:pubmed |
| pubmed-article:2342668 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2342668 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2342668 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2342668 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2342668 | lld:pubmed |
